Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-22-025712
Filing Date
2022-02-22
Accepted
2022-02-22 17:02:39
Documents
10
Effectiveness Date
2022-02-22

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm227095-1_s3asr.htm S-3ASR 193453
2 EXHIBIT 5.1 tm227095d2_ex5-1.htm EX-5.1 15781
3 EXHIBIT 23.1 tm227095d2_ex23-1.htm EX-23.1 3170
4 EXHIBIT 25.1 tm227095d2_ex25-1.htm EX-25.1 119586
5 EX-FILING FEES tm227095d2_ex-filingfees.htm EX-FILING FEES 35059
6 GRAPHIC tm227095d2_ex5-1img001.jpg GRAPHIC 9412
7 GRAPHIC tm227095d2_ex5-1img002.jpg GRAPHIC 2347
8 GRAPHIC tm227095d2_ex25-1img001.jpg GRAPHIC 278595
9 GRAPHIC tm227095d2_ex25-1img002.jpg GRAPHIC 284028
10 GRAPHIC lg_abbvie-pn.jpg GRAPHIC 43403
  Complete submission text file 0001104659-22-025712.txt   1219659
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-262908 | Film No.: 22659197
SIC: 2834 Pharmaceutical Preparations